导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 16.23% | 3353/4448 |
| 近一周 | 0.32% | 1333/4963 |
| 近一月 | -1.49% | 2978/4942 |
| 近一季 | -0.06% | 2075/4867 |
| 近半年 | 12.29% | 3340/4629 |
| 近一年 | 16.80% | 3235/4426 |
| 近两年 | 58.51% | 645/3936 |
| 近三年 | 50.93% | 341/3301 |
| 成立以来 | 1446.03% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2025 | - - |
-0.29% 3724/4617 |
4.09% 1549/4794 |
10.58% 3961/4965 |
- - |
| 2024 | 33.81% 49/4611 |
10.33% 110/4340 |
4.97% 346/4440 |
13.76% 1135/4543 |
1.57% 1121/4611 |
| 2023 | -0.90% 288/4209 |
4.84% 1042/3759 |
-7.55% 2902/3909 |
1.38% 152/4055 |
0.85% 373/4209 |
| 2022 | -12.42% 361/3571 |
-12.58% 541/2804 |
8.03% 1378/3205 |
-11.43% 1392/3430 |
4.70% 656/3570 |
| 2021 | -12.07% 1444/2712 |
0.15% 363/1745 |
-0.22% 1655/2232 |
-6.92% 1440/2560 |
-5.47% 2169/2708 |
| 2020 | 89.08% 85/1591 |
1.53% 299/1036 |
31.28% 216/1256 |
25.72% 17/1472 |
12.82% 814/1690 |
| 2019 | 59.59% 127/922 |
34.21% 219/3054 |
-2.41% 2082/3201 |
9.44% 258/939 |
11.34% 250/1014 |
| 2018 | -23.77% 265/667 |
- - |
- - |
- - |
-8.06% 1616/2977 |
| 2017 | 21.50% 148/531 |
- - |
- - |
- - |
- - |
| 2016 | -21.73% 325/455 |
- - |
- - |
- - |
- - |
| 2015 | 41.00% 245/433 |
- - |
- - |
- - |
- - |
| 2014 | 15.65% 298/432 |
- - |
- - |
- - |
- - |
| 2013 | 1.27% 345/398 |
- - |
- - |
- - |
- - |
| 2012 | 5.59% 190/459 |
- - |
- - |
- - |
- - |
| 2011 | -28.31% 311/392 |
- - |
- - |
- - |
- - |
| 2010 | -0.71% 218/335 |
- - |
- - |
- - |
- - |
| 2009 | 73.73% 83/270 |
- - |
- - |
- - |
- - |
| 2008 | -56.20% 186/215 |
- - |
- - |
- - |
- - |
| 2007 | 133.59% 40/165 |
- - |
- - |
- - |
- - |
| 2006 | 161.61% 6/107 |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 泰信发展主题混合 | 1.8400 | 37.93% |
| 创金合信全球医药生物股票发起(QDII)C | 1.7628 | 36.40% |
| 永赢先锋半导体智选混合发起C | 1.3037 | 32.44% |
| 汇添富黄金及贵金属(QDII-LOF-FOF)A | 1.7820 | 17.86% |
| 汇添富黄金及贵金属(QDII-LOF-FOF)C | 1.7620 | 17.70% |
| 汇添富纳斯达克生物科技ETF发起式联接(QDII)人民币C | 1.3564 | 17.05% |
| 国泰中证有色金属矿业主题ETF发起联接A | 1.6862 | 16.71% |
| 易方达供给改革混合 | 3.5514 | 13.22% |
| 信澳业绩驱动混合C | 1.7022 | 13.09% |
| 南方周期优选混合发起C | 1.5008 | 12.06% |
| 招商优质成长混合(LOF) VS. () |